Literature DB >> 8845936

Role of nitric oxide in neurodegenerative diseases.

J B Schulz1, R T Matthews, M F Beal.   

Abstract

Besides its role as a mediator of several physiological functions, nitric oxide appears to be a neurotoxin under conditions of excessive production, which suggests a role for nitric oxide in neurodegenerative diseases. An increasing body of evidence has implicated excitotoxicity as a mechanism of cell death in both acute and chronic neurologic diseases. Activation of excitatory amino acid receptors leads to activation of neuronal nitric oxide synthase by an increase in intracellular calcium concentrations. Nitric oxide may inhibit key enzymes of energy metabolism, damage DNA, deplete intracellular glutathione, and react with superoxide to form peroxynitrite. The latter is a highly reactive molecule, a potent oxidizing agent known to initiate lipid peroxidation, hydroxylation and nitration of aromatic amino acid residues, and sulfhydryl oxidation of proteins, and to decompose to nitrogen dioxide and species with hydroxyl-like reactivity. There now is evidence that the neuronal production of nitric oxide and the formation of peroxynitrite occurs in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845936     DOI: 10.1097/00019052-199512000-00016

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  13 in total

1.  Clinical and genetic study of a family with spinocerebellar ataxia type 1 (SCA1) and beta-thalassemia.

Authors:  V Pietrini; M Godani; S Calzetti; A Negrotti; B Castellotti; M C Riggio; C Toffoli
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidants.

Authors:  H T Rupniak; K A Joy; C Atkin; G Brown; J C Barnes; S R Doctrow; B Malfroy; T Wong; I K Anderson; C R Molloy; G I Mills; P Soden
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 3.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

4.  Effect of graded hypoxia on high-affinity Ca2+-ATPase activity in cortical neuronal nuclei of newborn piglets.

Authors:  O P Mishra; M Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

Review 5.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

6.  NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase.

Authors:  A S Mandir; M F Poitras; A R Berliner; W J Herring; D B Guastella; A Feldman; G G Poirier; Z Q Wang; T M Dawson; V L Dawson
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 7.  Mechanisms of action of brain insulin against neurodegenerative diseases.

Authors:  Mahesh Ramalingam; Sung-Jin Kim
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

8.  Nitration as a mechanism of Na+, K+-ATPase modification during hypoxia in the cerebral cortex of the guinea pig fetus.

Authors:  I Qayyum; A B Zubrow; Q M Ashraf; J Kubin; M Delivoria-Papadopoulos; O P Mishra
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

9.  The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.

Authors:  Marta Garcia; Peter Vanhoutte; Christiane Pages; Marie-Jo Besson; Emmanuel Brouillet; Jocelyne Caboche
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

10.  N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.

Authors:  Payman Nasr; Timothy Carbery; James W Geddes
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.